Close Menu

Merck Serono

Guardant is providing its Guardant 360 CDx test for a clinical trial of Merck's small molecule, c-Met kinase inhibitor called tepotinib.

The collaboration adds to a similar agreement Illumina struck with AstraZeneca, Janssen Biotech, and Sanofi last year.

Vall d'Hebron's Institute of Oncology will use the liquid biopsy-based OncoBEAM RAS test to research precision medicine approaches for metastatic colorectal cancer patients.

The customizable PCR plates may also be less expensive than the FDA-approved Therascreen kits.

NEW YORK (GenomeWeb) – Merck KGaA today said that it will collaborate with Sysmex Inostics on the development of a RAS biomarker mutation test for metastatic colorectal cancer.

Merck Serono has engaged Life Technologies to help it advance molecular diagnostics that can pick out best responders to its treatments.

NEW YORK (GenomeWeb News) – Life Technologies today said that it has inked a companion diagnostics deal with pharmaceutical firm Merck Serono for an undisclosed oncology target and eventually other therapeutic areas.

Quartz Bio, a newly minted bioinformatics consultancy outfit, is hoping to make its bread and butter by offering exploratory biomarker analysis and data management services to clients in the pharmaceutical industry.

NEW YORK (GenomeWeb News) – Merck Serono, the biopharmaceutical division of Merck KGaA, today said that it has spun out a bioinformatics firm, Quartz Bio, from its Entrepreneur Partnership Program launched earlier this year.

Merck KGaA and MDxHealth have extended an existing personalized medicine research collaboration so that the drug firm will fund the development, regulatory activities, and commercial launch of a companion diagnostic being advanced by MDxHealth for an investigational glioblastoma

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.